#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoinflammation with infantile enterocolitis Retinopathy of prematurity Endocrine ophthalmopathy Soft tissue sarcoma B precursor type acute leukaemia Squamous cell carcinoma of the hypopharynx KBG syndrome Neonatal asphyxia Warm autoimmune haemolytic anaemia Scedosporium infection Iron overload Bronchopulmonary dysplasia Colon cancer Congenital ectodermal dysplasia Macular telangiectasia More trials…

    Learn about Rare Diseases

    Sarcoma – Treatment Aicardi-Goutieres syndrome – Diagnostics Ewing’s sarcoma metastatic – Life with Disease Haemophagocytic lymphohistiocytosis – Basic Information Cystic fibrosis – Basic Information Acquired haemophilia Angelman’s syndrome Chronic granulomatous disease – Basic Information Advanced systemic mastocytosis – Life with Disease Idiopathic inflammatory myopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenylephrine Hydrochloride Lt3001 Mk-1167 Surzebiclimab Vorinostat Prilocaine Venetoclax AVTX-009 Etoposide Phosphate Capmatinib Epinephrine Miransertib Siponimod Revumenib Pitavastatin Calcium Ieramilimab Fenofibrate Micronised Histamine Hydrochloride Dolutegravir Sodium Rusfertide More therapies…

    Learn about Your Condition

    Incisional hernia Pruritus Tardive dyskinesia Bone sarcoma Hepatic adenoma Graft versus host disease Toxic nodular goitre Liposarcoma metastatic Asthmatic crisis Malignant melanoma Systemic scleroderma ROHHAD syndrome Hyperplasia adrenal Myotonic dystrophy Bacterial prostatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Regionale San Carlo

Azienda Ospedaliera Regionale San Carlo

Via Potito Petrone, Potenza, 85100, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effect of Phosphocreatine Sodium and Sodium Chloride in Patients Treated by Medical Emergency Teams with Conditions like Rapid Breathing or Low Blood Pressure

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Phosphocreatine Sodium
    • Sodium Chloride
    Italy

  • Study on Cetuximab-Based Treatment for Metastatic Colorectal Cancer in Patients with RAS/BRAF Wild Type Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Levofolinate
    • Cetuximab
    Italy

  • Study on Valproic Acid with Bevacizumab and Oxaliplatin/Fluoropyrimidine for Patients with RAS-Mutated Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Capecitabine
    • Fluorouracil
    Italy

  • Study Comparing Shortened vs Standard Chemotherapy with Rituximab for Initial Treatment of High Tumor Burden Follicular Lymphoma in Newly Diagnosed Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Italy

  • Study on the Effectiveness and Safety of Ibrutinib with Rituximab-CHOP for Untreated Patients with Diffuse Large B-cell Lymphoma at High Risk

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Ibrutinib
    Italy

  • Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Avelumab
    Italy

  • Study on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    • Glycerol
    • Prednisolone
    Italy

  • Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Deutivacaftor
    • Tezacaftor
    • Vanzacaftor
    Austria Belgium Czechia Denmark France Germany +10

  • Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Elexacaftor
    • Ivacaftor
    • Tezacaftor
    Austria Belgium Czechia France Germany Hungary +7

  • Study of Durvalumab and Regorafenib for Patients with Stage IV Colorectal Cancer with No Evidence of Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Durvalumab
    • Regorafenib
    Italy
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!